Broken Blood Vessels May Drive Alzheimer’s Decline

TL;DR: A new study reveals that impaired cerebrovascular function—the brain’s ability to regulate blood flow—correlates strongly with Alzheimer’s symptoms, offering a potential non-invasive way to detect early cognitive decline. Alzheimer’s disease has long been framed as a problem of toxic protein accumulation: amyloid plaques and tau tangles strangling neurons into silence. But what if the …

Read more

How FP802 Targets the NMDAR/TRPM4 Death Complex to Reverse Alzheimer’s

TL;DR: Researchers discovered a toxic interaction between two brain proteins—NMDAR and TRPM4—that drives neurodegeneration in Alzheimer’s disease, and a small molecule called FP802 that blocks this “death complex” and prevents cognitive decline in mice. Alzheimer’s disease devastates the brain through multiple pathways, but the exact triggering mechanisms remain frustratingly unclear. A new study in Molecular …

Read more

How the Human Brain Stores Memory: Content vs. Context Neurons

TL;DR: The brain stores content (what you remember) and context (when/where) in separate neural populations linked by real-time coordination, not pre-wired conjunctive cells—a design that trades speed for flexibility, allowing you to recognize a friend’s face across any setting or apply a principle learned once to infinitely new situations. For forty years, neuroscientists thought memory …

Read more

Psychedelics Double 5-Hz Brain Oscillations in Visual Cortex to Produce Hallucinations

TL;DR: A psychedelic drug that activates serotonin receptors dramatically amplifies slow 5-Hz brain oscillations in visual and memory regions, suggesting a mechanism for how hallucinogens distort perception by letting internal signals override external reality. Visual perception feels stable, seamless, continuous. But that stability is an illusion orchestrated by your brain. What neuroscientists have long wondered …

Read more

New Blood Test Detects Alzheimer’s Disease with 83% Accuracy Years Before Symptoms

TL;DR: A new blood test using three misfolded plasma proteins can identify Alzheimer’s disease with 83.44% accuracy, outperforming conventional biomarkers and offering a non-invasive screening tool years before cognitive symptoms appear. The holy grail of Alzheimer’s research isn’t a cure—yet. It’s catching the disease before memory starts to fade. By the time someone notices confusion, …

Read more

Video Game Addiction vs. Brain Activity & Response Inhibition: A Cued Go/NoGo Task Study

Video game addiction (VGA) is associated with significant deficits in response inhibition and preparatory processes, reflected by more commission errors and reduced N2 amplitudes in the cued Go/NoGo task. Highlights: Increased Commission Errors: Individuals with VGA made significantly more commission errors in NoGo trials compared to healthy controls, indicating impaired response inhibition. Faster Reaction Times: …

Read more

Omega-3 Fatty Acids & Souvenaid® May Slow Cognitive Decline in Alzheimer’s Disease (2024 Review)

Omega-3 supplements and Souvenaid® show potential in slowing cognitive decline in Alzheimer’s patients, though the evidence remains inconclusive. Highlights: Cognitive Decline Reduction: The CDR scale showed a significant reduction in cognitive decline progression with Omega-3 supplementation (SMD = −0.4127, 95% CI: [−0.5926; −0.2327]). Mixed Cognitive Outcomes: 58% of studies reported positive cognitive effects from Omega-3 …

Read more

Guanfacine Reverses Cognitive Impairment in Long COVID (2024 Case Report)

Guanfacine extended release (GXR) may effectively improve cognitive impairments and brain activity in long-COVID patients. Highlights: Patient Presentation: A 32-year-old woman experienced cognitive impairments such as difficulty in word recall, reading, and writing, and delayed task completion following COVID-19 infection. Baseline Assessment: Initial tests showed poor performance in attention, working memory, and executive function, with …

Read more

ACOT7 Biomarker May Help in Early Diagnosis of Alzheimers Disease (2024 Study)

ACOT7 shows promise as a non-invasive serum biomarker for Alzheimer’s disease (AD) with high diagnostic accuracy. Highlights: Increased Expression: ACOT7 levels were significantly elevated in AD patients and animal models compared to controls. Correlation with Cognitive Decline: A strong negative correlation was observed between serum ACOT7 levels and MMSE scores (r = -0.85; p < …

Read more

Blood Urea Nitrogen (BUN) & Creatinine Ratio vs. Cognition & Depression (2024 Study)

Elevated blood urea nitrogen and creatinine ratio (BUNCr) is associated with decreased cognitive function and increased depressive symptoms, with depressive symptoms mediating part of the relationship between BUNCr and cognitive decline. Highlights: BUNCr has a negative association with cognitive function, with higher BUNCr levels linked to lower cognitive performance. BUNCr is positively associated with depressive …

Read more